Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia

European Journal of Cancer and Clinical Oncology - Tập 26 - Trang 777-779 - 1990
Nick R. Lemoine1, Fiona S. Wyllie2, Johan R. Lillehaug3, Susan L. Staddon1, Christine M. Hughes1, Rein Aasland3, Jonathan Shaw2, Jan E. Varhaug3, Christopher L. Brown4, William J. Gullick1, David Wynford-Thomas2
1ICRF Molecular Oncology Group, MRC Cyclotron Building, Hammersmith Hospital, London W12, U.K.
2CRC Thyroid Tumour Biology Research Group, Department of Pathology, University of Wales College of Medicine, Cardiff, U.K.
3Laboratory of Biotechnology, Departments of Biochemistry and Surgery, University of Bergen, Norway
4Department of Morbid Anatomy, Institute of Pathology, London Hospital, London E1, U.K.

Tài liệu tham khảo

Downward, 1984, Close similarity of the epidermal growth factor receptor and the v-erbB oncogene protein sequences, Nature, 307, 521, 10.1038/307521a0 Todaro, 1980, Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors, 77, 5258 Yamamoto, 1986, Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor, Nature, 319, 230, 10.1038/319230a0 Yamamoto, 1986, High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines, Cancer Res, 46, 414 Libermann, 1985, Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin, Nature, 313, 144, 10.1038/313144a0 Slamon, 1989, Studies of the HER-2/neu proto oncogene in human breast and ovarian cancer, Science, 244, 707, 10.1126/science.2470152 Venter, 1987, Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas—immunohistological assessment correlates with gene amplification, Lancet, ii, 69, 10.1016/S0140-6736(87)92736-X Van de Vijver, 1988, Immunohistochemical detection of the neu protein in tissue sections of human breast tumours with amplified neu DNA, Oncogene, 2, 175 Yokota, 1988, Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue, Oncogene, 2, 283 Falck, 1989, c-erbB-2 oncogene product staining in gastric adenocarcinoma, 159, 107 D'Emilla, 1989, Expression of the c-erbB-2 gono product (p185) at different stages of neoplastic progression in the colon, Oncogene, 4, 1233 Schneider, 1989, Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer, Cancer Res, 49, 4968 Hall, 1990, The c-erbB-2 oncogene product in human pancreatic cancer, J Pathol, 161, 195, 10.1002/path.1711610305 Aasland, 1988, Expression of oncogenes in thyroid tumours: coexpression of c-erbB-2/neu and c-erbB, Br J Cancer, 57, 358, 10.1038/bjc.1988.82 Segatto, 1988, Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene, Mol Cell Biol, 8, 5570, 10.1128/MCB.8.12.5570 Wyllie, 1989, Structure and expression of nuclear oncogenes in multistage thyroid tumorigenesis, Br J Cancer, 60, 561, 10.1038/bjc.1989.313 Xu, 1984, Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells, Nature, 309, 806, 10.1038/309806a0 Ullrich, 1984, Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells, Nature, 309, 418, 10.1038/309418a0 Hung MC, Thompson KL, Chiu IM, Rosner MR. Characterization of rodent epidermal growth factor receptor transcripts using a mouse genomic probe. Biochem Biophys Res Commun141, 1109–1115. Semba, 1985, A v-erbB related proto-oncogene, c-erbB-2, is distinct form the c-erbB-1/EGF receptor gene and is amplified in a human salivary gland adenocarcinoma, 82, 6497 Lemoine NR, Mayall ES, Wyllie FS, et al. High frequency of ras oncogene activation at all stages of human thyroid tumorigenesis. Oncogene4, 159–164. Higuchi, 1989, Simple and rapid preparation of samples for PCR, 31 Lemoine, 1990, Absence of activating transmembrane mutations in the c-erbB-2 protooncogene in human breast cancer, Oncogene, 5, 237 Fusco, 1987, A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases, Nature, 328, 170, 10.1038/328170a0 Bongarzone, 1989, High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma, Oncogene, 4, 1457 Suarez, 1990, Presence of mutations in all three ras genes in human thyroid tumors, Oncogene, 5, 565 Williams DW, Williams ED, Wynford-Thomas D. Loss of dependence of IGF-1 for proliferation of human thyroid adenoma cells. Br J Cancer57, 535–539. Jasani, 1990, Immunodetectable TGF-beta associated with malignancy in a human epithelial neoplasm, Growth Factors, 2, 149, 10.3109/08977199009071501